* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Edronax (reboxetine) is a prescription antidepressant medication used to treat major depressive disorder (MDD) in adults. Major depressive disorder is a mental health condition that can affect your mood, thoughts, energy levels, sleep, appetite, and ability to carry out everyday activities.
Edronax contains reboxetine, an antidepressant that works by increasing the availability of norepinephrine, a chemical messenger in the brain involved in mood, attention, and energy regulation.
Your healthcare provider may prescribe Edronax to help manage the following condition:
Depression can affect people differently. Some individuals experience mainly emotional symptoms, while others may notice physical changes, such as low energy, disrupted sleep, or difficulty completing their usual responsibilities.
Edronax may help relieve symptoms of depression over time, making it easier to participate in daily activities, maintain relationships, and manage everyday responsibilities.
However, Edronax does not provide immediate relief. Like many antidepressants, it usually needs to be taken regularly for several weeks before its full benefits can be assessed.
Your healthcare provider will determine whether Edronax is appropriate for you based on your symptoms, medical history, previous antidepressant treatments, and other medications you may be taking.
Edronax contains reboxetine, which belongs to a group of antidepressants called selective norepinephrine reuptake inhibitors (NRIs).
Norepinephrine, also known as noradrenaline, is a chemical messenger called a neurotransmitter. It helps nerve cells communicate with one another and plays an important role in regulating mood, alertness, attention, and energy.
Normally, after norepinephrine is released between nerve cells, some of it is taken back up into the nerve cell that released it. This process is called reuptake.
Reboxetine works by blocking the reuptake of norepinephrine, allowing more of it to remain available between nerve cells.
By increasing norepinephrine activity, Edronax may help improve certain symptoms associated with depression.
The medication works in several ways:
Unlike selective serotonin reuptake inhibitors (SSRIs), which primarily affect serotonin, Edronax mainly targets norepinephrine.
It is also different from serotonin-norepinephrine reuptake inhibitors (SNRIs), which affect both serotonin and norepinephrine.
Although Edronax changes norepinephrine activity relatively quickly, improvements in depressive symptoms usually develop gradually over several weeks.
Edronax does not usually improve depression symptoms immediately. Some people may begin to notice improvements in their mood, energy, or motivation after approximately two weeks of treatment. However, it may take several additional weeks to evaluate the full benefits.
The time needed to respond to Edronax varies depending on the severity of your depression, your prescribed dose, and how your body responds to the medication.
Continue taking Edronax exactly as prescribed, even if you do not notice immediate improvement. Do not increase your dosage or stop treatment without consulting your healthcare provider.
Edronax is intended for adults with major depression and may also be used to maintain improvement in people who have responded to treatment.
It is not recommended for children and adolescents under 18 years of age. Tell your healthcare provider if you have a history of seizures, bipolar disorder, heart problems, glaucoma, or liver or kidney disease before starting treatment.
Like other antidepressants, Edronax may be associated with worsening mood or suicidal thoughts, particularly when starting treatment or changing doses. Contact your healthcare provider promptly if your depression worsens or you notice unusual changes in your mood or behaviour. Seek emergency help if you are at immediate risk of harming yourself.
Edronax helps treat depression by increasing norepinephrine activity in the brain. Taking it consistently as prescribed and attending regular follow-up appointments can help your healthcare provider assess your response and determine whether the treatment is appropriate.
Edronax is a prescription antidepressant used to treat major depressive disorder in adults. It works by increasing the availability of norepinephrine, a chemical messenger in the brain that helps regulate mood, energy, and concentration.
Edronax is available as a 4 mg oral tablet and can be taken with or without food. Your healthcare provider will determine the appropriate dosage based on your medical condition, age, response to treatment, and any other medications you are taking.
Edronax is usually taken twice daily, with one dose in the morning and another later in the day. Taking your medication at approximately the same times each day helps maintain a consistent treatment routine.
It may take one to two weeks before you begin to notice improvements in your mood or energy levels. However, the full benefits of treatment may take several weeks to develop.
The usual recommended starting dose of Edronax for adults is 4 mg twice daily, for a total of 8 mg per day.
Your healthcare provider may adjust your dose depending on how well your depression symptoms improve and whether you experience side effects.
Some people may require a higher dose if their symptoms do not respond adequately to the initial treatment. However, dose increases should only be made under medical supervision.
Older adults and people with liver or kidney problems may require a lower starting dose or additional monitoring.
Do not increase, decrease, or stop your medication without consulting your healthcare provider. Taking more Edronax than prescribed may increase the risk of unwanted side effects.
Follow these steps to take Edronax safely and correctly:
Follow Your Prescribed Dosage
Always take Edronax exactly as directed by your healthcare provider.
The usual adult starting dose is 4 mg twice daily, but your dosage may differ depending on your age, medical history, and response to treatment.
Do not take additional tablets or increase your dose if your depression symptoms do not improve immediately.
Your healthcare provider will assess your progress and determine whether a dosage adjustment is necessary.
Take Edronax at the Same Times Each Day
Taking Edronax at approximately the same times every day can help you maintain a consistent treatment schedule.
For example, your healthcare provider may recommend taking your first dose with breakfast and your second dose later in the afternoon or evening.
Some people experience difficulty sleeping while taking Edronax. If this happens, speak with your healthcare provider about whether adjusting the timing of your second dose may help.
Do not change your dosing schedule without medical advice.
Allow Time for the Medication to Work
Edronax does not provide immediate relief from depression symptoms.
Some people may notice improvements in their energy, motivation, or mood within the first one to two weeks of treatment.
However, more noticeable improvements may take several additional weeks.
Continue taking Edronax as prescribed, even if you do not feel better right away.
If your symptoms do not improve after several weeks or become worse, contact your healthcare provider. They may need to review your dosage or recommend another treatment.
Do Not Stop Taking Edronax Suddenly
Do not stop taking Edronax without consulting your healthcare provider, even if your depression symptoms have improved.
Stopping antidepressant treatment abruptly may cause uncomfortable symptoms or allow depression symptoms to return.
Your healthcare provider can help determine when it may be appropriate to discontinue treatment and whether your dose should be reduced gradually.
Continue attending follow-up appointments so your healthcare provider can monitor your progress and response to treatment.
If you forget to take a dose of Edronax, take it as soon as you remember.
However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular treatment schedule.
Do not take two doses at once or double your next dose to make up for a missed tablet. Taking extra medication may increase your risk of side effects.
If you frequently forget your medication, consider setting a daily reminder or taking your tablets as part of your regular morning and evening routine.
If you are unsure what to do after missing a dose, ask your healthcare provider or pharmacist for advice.
Contact your healthcare provider if your depression symptoms do not begin to improve after several weeks or if you experience side effects that interfere with your daily activities.
You should also seek medical advice if you experience persistent dizziness, an unusually fast heartbeat, difficulty urinating, severe sleep disturbances, or increased anxiety.
Antidepressants may sometimes be associated with worsening depression, agitation, or suicidal thoughts, particularly when starting treatment or changing doses.
Contact your healthcare provider promptly if you notice sudden changes in your mood, behavior, or emotional well-being. Seek emergency assistance if you feel at immediate risk of harming yourself.
Always take Edronax exactly as prescribed. Taking your tablets consistently, following your recommended dosage, and attending regular follow-up appointments can help you manage depression while reducing the risk of unwanted side effects.
Edronax (Roboxetine) is available in the following forms and strength:
Before taking Edronax, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Edronax is a prescription antidepressant used to treat major depressive disorder in adults. It works by increasing norepinephrine activity in the brain, which may help improve mood, energy, concentration, and other symptoms of depression.
Although Edronax can help manage depression, it may cause side effects or worsen certain medical conditions. Your healthcare provider may recommend additional monitoring or adjust your dosage based on your health and response to treatment.
Edronax should be used cautiously in people with kidney disease or reduced kidney function.
Your kidneys help remove medications and their breakdown products from your body. If your kidneys are not working properly, reboxetine may remain in your bloodstream for longer, increasing your risk of side effects.
Your healthcare provider may recommend a lower starting dose if you have kidney impairment.
Tell your healthcare provider if you have a history of chronic kidney disease, reduced kidney function, or abnormal kidney function tests.
Your healthcare provider may recommend blood tests or additional monitoring to determine whether Edronax is suitable for you.
Do not change your dosage without medical advice.
Edronax should also be used cautiously in people with liver disease or reduced liver function.
Your liver helps break down reboxetine so your body can eliminate it. If your liver is not functioning normally, the medication may accumulate in your bloodstream and increase the likelihood of unwanted effects.
People with moderate to severe liver impairment may require a lower starting dose.
Tell your healthcare provider if you have hepatitis, cirrhosis, elevated liver enzymes, or another liver condition.
Your healthcare provider will consider your liver function before determining the appropriate dosage and may recommend additional monitoring during treatment.
Contact your healthcare provider if you experience unusual or persistent symptoms that could suggest a medication-related problem.
Edronax should be used with caution in people with a history of seizures or epilepsy.
Although seizures are uncommon, they have been reported in people taking reboxetine.
The medication has not been extensively studied in patients with seizure disorders, so careful medical supervision is important.
Tell your healthcare provider if you have previously experienced seizures, epilepsy, or another neurological condition that may increase your risk of seizures.
Your healthcare provider will assess whether Edronax is appropriate for you and whether another antidepressant may be safer.
If you experience a seizure while taking Edronax, seek immediate medical attention. Reboxetine should be discontinued if a seizure occurs, with further treatment directed by your healthcare provider.
Edronax should be used cautiously in people with heart disease, high blood pressure, or a history of abnormal heart rhythms.
Reboxetine affects norepinephrine activity, which can influence your heart rate and blood pressure.
Some people may experience a faster heartbeat, heart palpitations, increased blood pressure, or dizziness when standing up.
Tell your healthcare provider if you have coronary artery disease, hypertension, an irregular heartbeat, or another cardiovascular condition.
Your healthcare provider may recommend monitoring your blood pressure and heart rate, particularly when you first begin treatment or after a dosage adjustment.
Contact your healthcare provider if you experience persistent palpitations, unusual dizziness, or significant changes in your blood pressure.
Seek emergency medical attention if you develop chest pain, fainting, or severe breathing difficulties.
Edronax may interact with certain antidepressants and medications that affect chemical messengers in the brain.
Although Edronax mainly acts on norepinephrine, combining it with medications that increase serotonin activity may raise the risk of a potentially serious condition called serotonin syndrome.
Medications that may require special attention include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), certain other antidepressants, and monoamine oxidase inhibitors (MAOIs).
Examples of SSRIs include fluoxetine, sertraline, and escitalopram.
Combining Edronax with an MAOI should be avoided because of the risk of serious reactions. Other antidepressant combinations may occasionally be considered by a specialist, but they require careful assessment and monitoring.
Tell your healthcare provider about all antidepressants and mental health medications you currently take or have recently stopped.
Do not combine medications, switch antidepressants, or change your dosage without medical supervision.
Serotonin syndrome is a potentially life-threatening reaction that may occur when certain medications affect serotonin activity.
Although Edronax primarily increases norepinephrine rather than serotonin, cases of serotonin syndrome have been reported with reboxetine, particularly when combined with other serotonergic medications.
Possible symptoms include:
Seek emergency medical attention if you develop a combination of these symptoms, particularly after starting a new medication or increasing your dose.
Serotonin syndrome requires prompt medical evaluation and treatment.
Edronax should be used cautiously in people who have difficulty urinating or a history of prostate problems.
Reboxetine may affect bladder function and make it more difficult for some people to empty their bladder completely.
This may be particularly concerning for people with an enlarged prostate, also called benign prostatic hyperplasia (BPH), or a history of urinary retention.
Tell your healthcare provider if you experience a weak urine stream, difficulty starting urination, frequent urges to urinate, or a feeling that your bladder has not emptied completely.
Your healthcare provider may recommend additional monitoring or consider another antidepressant if you already have significant urinary problems.
Contact your healthcare provider promptly if you develop new or worsening difficulty urinating.
Seek urgent medical attention if you are unable to urinate, especially if you experience severe lower abdominal pain or swelling.
Edronax should be used cautiously in people with bipolar disorder or a history of mania or hypomania.
Antidepressants can sometimes trigger a manic or hypomanic episode in people who are susceptible to these mood changes.
Mania is a period of unusually elevated or irritable mood accompanied by increased energy and activity. Hypomania involves similar but generally less severe symptoms.
Possible warning signs include
Tell your healthcare provider if you have bipolar disorder or have previously experienced manic or hypomanic episodes.
A history of mania or hypomania does not automatically mean Edronax is prohibited in every case. However, it requires careful assessment and close monitoring, and antidepressant treatment without an appropriate bipolar disorder management plan may be unsuitable.
Contact your healthcare provider promptly if you or someone close to you notices sudden changes in your mood, sleep patterns, energy, or behavior.
Tell your healthcare provider if you have a bleeding disorder, experience frequent unexplained bruising, or take medications that increase your risk of bleeding.
Examples include anticoagulants such as warfarin and apixaban, antiplatelet medications such as aspirin and clopidogrel, and certain anti-inflammatory pain relievers.
Unlike antidepressants that strongly affect serotonin, Edronax primarily acts on norepinephrine. A significant bleeding risk is not as well established for reboxetine as it is for some serotonin-affecting antidepressants.
However, reviewing your medication list is still important, particularly if you have a history of unusual bleeding or take several medications.
Contact your healthcare provider if you develop unexplained bruising, frequent nosebleeds, or bleeding that takes longer than usual to stop.
Seek urgent medical attention if you experience severe bleeding, vomiting blood, or black, tarry stools.
Do not take Edronax if you are allergic to reboxetine or any other ingredient in the tablets.
An allergic reaction may cause itching, hives, a skin rash, redness, or swelling.
In rare cases, a severe allergic reaction may occur.
Tell your healthcare provider if you have previously experienced an allergic reaction to Edronax or another antidepressant medication.
Stop taking Edronax and contact your healthcare provider if you develop signs of an allergic reaction.
Seek emergency medical attention immediately if you experience difficulty breathing, severe dizziness, or swelling of your face, lips, tongue, or throat.
Like other antidepressants, Edronax may be associated with worsening depression, unusual behaviour changes, or suicidal thoughts, particularly during the first few weeks of treatment or after dosage changes.
The risk of antidepressant-associated suicidal behaviour may be higher in younger adults, especially those under 25 years of age.
Tell your healthcare provider promptly if you notice worsening sadness, increased anxiety, agitation, unusual impulsiveness, or thoughts of self-harm.
Family members or caregivers may also help identify concerning changes in mood or behaviour.
Regular follow-up appointments are particularly important when starting Edronax or adjusting your dosage.
If you feel at immediate risk of harming yourself, seek emergency medical assistance.
Edronax is primarily broken down by a liver enzyme called CYP3A4. Certain medications can affect this enzyme and change the amount of reboxetine in your bloodstream.
For example, some antifungal medications, including ketoconazole and itraconazole, and certain antibiotics, including erythromycin, may increase reboxetine levels and raise the risk of side effects.
Other medications, such as carbamazepine and rifampin, may reduce reboxetine levels and affect how well treatment works.
Tell your healthcare provider or pharmacist about all medications you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.
Do not start or stop another medication without checking whether it can interact with Edronax.
Contact your healthcare provider if you experience persistent dizziness, a rapid heartbeat, difficulty urinating, worsening anxiety, or unusual changes in your mood while taking Edronax.
You should also seek medical advice if your depression symptoms become worse, you develop symptoms of mania or hypomania, or you experience side effects that interfere with everyday activities.
Seek emergency medical attention if you experience a seizure, severe allergic reaction, symptoms of serotonin syndrome, or feel at immediate risk of harming yourself.
Always take Edronax exactly as prescribed. Informing your healthcare provider about existing medical conditions, following your recommended dosage, and attending regular follow-up appointments can help you manage depression while reducing the risk of serious side effects.
Edronax is not considered addictive and is not known to cause the same type of drug dependence associated with medications such as opioids or benzodiazepines. Edronax belongs to a class of antidepressants called selective norepinephrine reuptake inhibitors (NRIs). It works by increasing the availability of norepinephrine, a chemical messenger in the brain that helps regulate mood, energy, and concentration. Although Edronax is not considered addictive, stopping the medication suddenly may cause uncomfortable symptoms or lead to a return of depression symptoms. Some people may experience dizziness, anxiety, headaches, sleep disturbances, or changes in mood after abruptly stopping antidepressant treatment. The likelihood and severity of these symptoms can vary between individuals. If you have been taking Edronax for an extended period, speak with your healthcare provider before stopping treatment. They may recommend gradually reducing your dosage to help minimize potential discontinuation symptoms. Do not increase your dosage, stop taking the medication, or change your treatment schedule without medical advice.
Weight gain is not considered a common side effect of Edronax, although individual responses to antidepressant medications can vary. Some people may notice changes in their appetite or body weight during treatment. These changes may be related to the medication, improvements in depression symptoms, changes in eating habits, or other health factors. Unlike some antidepressants that are more frequently associated with increased appetite and weight gain, Edronax is generally considered to have a relatively limited effect on body weight. However, this does not mean weight changes cannot occur. If your appetite improves as your depression symptoms become more manageable, you may begin eating more regularly, which could contribute to weight gain. Other people may experience reduced appetite or changes in weight for different reasons. Maintaining balanced eating habits, regular physical activity, and a consistent sleep schedule can help support your overall health during treatment. Contact your healthcare provider if you experience significant or unexpected weight gain or weight loss while taking Edronax. Your healthcare provider can help determine whether the changes are related to your medication, your depression symptoms, or another medical condition.
Like other antidepressant medications, Edronax may be associated with an increased risk of suicidal thoughts or behavior in some people, particularly when starting treatment or adjusting the dosage. This risk is especially important in children, adolescents, and young adults under 25 years of age. Edronax is not recommended for individuals younger than 18 years old. Although Edronax is prescribed to help improve depression symptoms, some people may initially experience increased anxiety, restlessness, agitation, or unusual mood changes before the medication reaches its full effect. It is important to monitor your thoughts, emotions, and behavior closely during the first few weeks of treatment and after any dosage adjustments. Warning signs may include worsening depression, increased sadness, feelings of hopelessness, or emotional distress. Some people may also experience unusual anxiety, nervousness, irritability, or agitation. Sudden changes in behavior, such as increased impulsiveness or acting differently from your usual self, should also be taken seriously. Other concerning symptoms include significant sleep disturbances, persistent insomnia, or new or worsening thoughts of self-harm or suicide. Contact your healthcare provider immediately if you notice any of these symptoms, particularly if they are new, severe, or becoming worse. Family members, friends, or caregivers may also help recognize unusual changes in your mood or behavior during treatment. If you experience suicidal thoughts or feel at immediate risk of harming yourself, seek emergency medical assistance. In Canada, you can also call or text 988 to receive suicide crisis support. Do not stop taking Edronax suddenly without consulting your healthcare provider, unless you are experiencing a serious reaction that requires emergency treatment. Abruptly stopping antidepressant medication may cause uncomfortable symptoms or increase the risk of your depression returning. Regular follow-up appointments are important throughout treatment, especially when you first begin taking Edronax or when your dosage changes. Your healthcare provider will monitor your symptoms, assess how well the medication is working, and determine whether any adjustments are needed to keep your treatment safe and effective.
Edronax may be prescribed for long-term treatment of major depressive disorder, depending on your symptoms, medical history, and response to the medication. Depression is a condition that can improve with treatment but may return over time. Continuing antidepressant medication after your symptoms improve can help reduce the risk of depression returning. Your healthcare provider may recommend continuing Edronax for at least six months after your depression symptoms have improved, depending on your individual circumstances. People who have experienced repeated episodes of depression, severe symptoms, or a high risk of relapse may benefit from a longer treatment period. Although information about the long-term safety and effectiveness of Edronax is more limited than for some commonly prescribed antidepressants, studies have evaluated its use for maintaining improvement in depression symptoms. During long-term treatment, your healthcare provider may recommend regular appointments to assess your mood, overall health, and possible side effects. They may also review whether your current dosage remains appropriate and whether continued treatment is necessary. Do not stop taking Edronax simply because you feel better. Stopping antidepressant treatment too early may increase the risk of your depression symptoms returning. If your healthcare provider determines that you no longer need Edronax, they may recommend gradually reducing your dosage rather than stopping suddenly. Always take Edronax exactly as prescribed. Regular follow-up appointments, monitoring changes in your mood, and discussing side effects with your healthcare provider can help ensure that your depression treatment remains appropriate and effective over time.
| Generic name: | Roboxetine |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 4mg |
| Quantities Available: | 60 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Edronax (reboxetine) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Edronax is commonly prescribed in dosages of 4 mg, taken twice daily. For a 90-day supply, this means you would order 180 tablets (90 days x 2 tablets per day).
No, we do not sell reboxetine directly on our website. However, you can still enjoy low prices on Edronax, which contains reboxetine as an active ingredient. To purchase Edronax, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Edronax (reboxetine) to both the United States and Puerto Rico.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Edronax (Roboxetine). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Edronax (Roboxetine).
REVIEWS